Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-25-003460
Filing Date
2025-11-14
Accepted
2025-11-14 14:44:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12551
  Complete submission text file 0000930413-25-003460.txt   14527
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Subject) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90660 | Film No.: 251484762
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 2 OVERHILL ROAD SCARSDALE NY 10583
Business Address 2 OVERHILL ROAD SCARSDALE NY 10583 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SCHEDULE 13G/A